What is Omeros Corp (OMER)?
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company targets inflammation, central nervous system disorders, and hematologic conditions. Its research and development efforts include both proprietary and partnered programs, aiming to address unmet medical needs. Omeros operates with a pipeline that encompasses multiple stages of clinical development, including product candidates for diseases such as schizophrenia and thrombotic microangiopathy. The company engages in collaborations to advance its therapeutic candidates and expand its scientific capabilities. Omeros is headquartered in Seattle, Washington, and maintains facilities for research, development, and manufacturing. Its operations emphasize innovation in drug discovery and the application of novel therapeutic approaches.
Omeros Corp Stock Price Today: Live Overview
The price today is shaped by ongoing market flows, with Omeros Corp currently at $11.22. During the trading day, prices have ranged from $11.07 to $11.64, reflecting a 0% change.
FAQ: Omeros Corp (OMER)
What is the current price of OMER stock?
The current trading price stands at $11.22.
Does OMER pay dividends?
Omeros Corp pays dividends.
Does OMER have a formal corporate presence or regional headquarters in the UAE?
Omeros Corp operates through partners and distributors in the UAE without an official regional office or subsidiary.
What is OMER best known for?
Omeros Corp is most famous for its development of therapeutic drugs targeting inflammation and immune system disorders.
What assets are typically shown together with OMER?
Commonly shown alongside OMER: iShares MSCI Japan Small-Cap ETF, Millicom International Cellular SA, Grupo Aval Acciones Y Valores SA - ADR
Latest shares articles



